Researchers have discovered a circuit in the brain that is necessary for unlearning fear. Published in Nature Communications, the study details the role of dopamine in ensuring that rats stop being afraid when there isn't anything to be afraid of anymore.
Like animals, people develop conditioned responses, especially if strong negative emotions are involved. This fact was used beautifully in the movie Jaws as the simple "da-da ... da-da" frightened millions without anyone needing to actually be chased or killed by a shark. Normally, fearful reactions will lessen over time as the conditioned stimulus (the music) is dissociated from the fearful experience (watching the movie). This is called fear extinction. When fear extinction does not happen normally, it can lead to anxiety disorders such as post-traumatic stress or phobias.
In order to understand how the brain regulates both the normal and pathological situations, the team performed a series of experiments in rats as they extinguished fearful associations. They reasoned that in order for fear to be extinguished, first an animal needs to recognize when an expected fearful event does not happen. As dopamine neurons in some parts of the brain are known to be active when expected unpleasant events don't happen, the team looked at dopamine neurons in a part of the brain called the VTA.
After conditioning rats to associate a specific sound (think of it as their Jaws music) with an aversive experience (a mild footshock), the team then began the extinction process. As expected, when the sound was played many times without the footshock, rats stopped behaving as if they were afraid of the sound. However, when VTA dopamine neurons were silenced just after playing the sound--exactly when the rats expected their feet to be shocked--they could not unlearn the fear response. This showed that without VTA dopamine activity at that specific time, the mental link between the sound and the shock could not be removed.
But what exactly does the VTA dopamine activity do? This was not a simple question to answer because not all VTA dopamine neurons are connected to the same brain regions. Some are connected to brain regions known for their role in storing extinction memories, while others are connected areas related to reward learning. Optogenetics allowed the team to block each of these pathways separately, and they found that they both affected fear extinction, but in opposite ways: blocking the reward pathway prevented fear extinction, while blocking the other pathway enhanced fear extinction. The optogentic experiments indicate that a specific dopamine projection to the nucleus accumbens medial shell is partially responsible for fear extinction. In contrast, a separate dopamine projection to the medial prefrontal cortex opposes extinction learning.
While the results are simple enough, obtaining them required technological effort. The team leader explains, "This finding was possible because we were able to manipulate dopamine neurons based on their unique brain connectivity. We used both genetic and brain-circuit specific technologies coupled with techniques for manipulating neural electrical activity in anatomically and genetically defined cell populations." With this optogenetic setup, they were able to physically shine light into the brain and silence specific dopamine cell populations, which revealed their role in fear extinction.
Now that they have discovered two dopamine pathways that can regulate fear extinction in different ways, the team is working on ways to target these neurons with traditional pharmacology rather than optogenetics. "Pharmacologically targeting the dopamine system will likely be an effective therapy for psychiatric conditions such as anxiety disorders when combined with clinically proven behavioral treatments such as exposure therapy," says the author. "In order to provide effective, mechanism-based treatments for these conditions, future pre-clinical work will need to use molecular strategies that can separately target these distinct dopamine cell populations."
https://www.nature.com/articles/s41467-018-04784-7
Latest News
TB blood test which could d…
By newseditor
Posted 27 Mar
Propionate supplementation…
By newseditor
Posted 27 Mar
Role of human Kallistatin i…
By newseditor
Posted 26 Mar
Addressing both flu and COV…
By newseditor
Posted 26 Mar
How the brain senses body p…
By newseditor
Posted 26 Mar
Other Top Stories
Omega-3 may block psychosis years later
Read more
A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerat…
Read more
Sleep apnea and brain damage
Read more
PTSD could be prevented by blocking memory consolidation pathway!
Read more
Body fat hormone leptin influences runner's high
Read more
Protocols
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Profiling native pulmonary…
By newseditor
Posted 08 Mar
Publications
Integrated plasma proteomic…
By newseditor
Posted 27 Mar
APP antisense oligonucleoti…
By newseditor
Posted 27 Mar
Targeting Erbin-mitochondri…
By newseditor
Posted 27 Mar
Regulation of Zbp1 by miR-9…
By newseditor
Posted 27 Mar
Pain-free oral delivery of…
By newseditor
Posted 27 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar